Organigram pauses some cannabis production over labeling dispute

Canadian cannabis producer Organigram Holdings said it is pausing production of its lozenge product in a 100-milligram THC package pending a resolution over an ongoing dispute with Health Canada.

The Toronto-headquartered company said it received a notification from Health Canada claiming the products were incorrectly classified and labeled as “extract” rather than “edible.”

ADVERTISEMENT

Organigram is one of a number of companies to have received such a notification this year.

In January, MJBizDaily reported that the federal cannabis regulator had begun asking some licensed marijuana companies to stop selling certain products the agency said were incorrectly classified and labeled as “extracts” rather than “edibles.”

From a packaging perspective, the distinction is important because any cannabis product classified as an “extract” has 100 times more allowable THC per package than a product considered an “edible,” making it more appealing to certain consumers.

Organigram launched the lozenge product

The post Organigram pauses some cannabis production over labeling dispute appeared first on GrowCola.com.

Canadian cannabis producer Organigram Holdings said it is pausing production of its lozenge product in a 100-milligram THC package pending… Continue reading
The post Organigram pauses some cannabis production over labeling dispute appeared first on GrowCola.com. 

Leave a Reply

Your email address will not be published. Required fields are marked *

× Whatsapp